Brain HealthHidden Drivers Keep Rheumatoid Arthritis Pain Alive Long After Inflammation Fades
Researchers at Semmelweis University have identified why many rheumatoid arthritis patients continue to suffer pain and fatigue even after standard anti-inflammatory treatment brings measurable disease activity under control. Publishing in Nature Reviews Rheumatology and The Lancet Rheumatology, the team found that depression, poor sleep, obesity, and smoking can form self-reinforcing cycles that keep symptoms active regardless of inflammation levels. They propose using the established treat-to-target monitoring framework as an early warning system: when inflammation markers improve but symptoms persist, clinicians should investigate these secondary drivers rather than automatically escalating medication. The approach has already been cited over a thousand times internationally and shows promise for improving outcomes in the 6–28% of RA patients classified as difficult to treat.
